Concepedia

Amy Loercher

AL

10

Publications

815

Citations

10

H-Index

1997

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (United States)

The University of Texas MD Anderson Cancer Center

Centre National de la Recherche Scientifique

Karolinska Institutet

Amy Loercher is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, ovarian cancer, and pharmacology.

ORCID

Top concepts

Publications per year

1997–2020

10

Publications

10

MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A

Amy Loercher, Elizabeth M.H. Tank, Rachel B. Delston et al. · The Journal of Cell Biology · 2004 · 257 citations · Full text

Identification of an IL-10-Producing HLA-DR-Negative Monocyte Subset in the Malignant Ascites of Patients with Ovarian Carcinoma That Inhibits Cytokine Protein Expression and Proliferation of Autologous T Cells

Amy Loercher, M A Nash, John J. Kavanagh et al. · The Journal of Immunology · 1999 · 174 citations · Full text

, , +16

Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma

Amy Loercher, Justin L. Ricker, April Howard et al. · Cancer Research · 2004 · 166 citations · Full text

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Signe Hässler, Delphine Bachelet, Julianne Duhazé et al. · PLoS Medicine · 2020 · 55 citations · Full text

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.

Bohuslav Melichar, Gabriella Ferrandina, Claire F. Verschraegen et al. · PubMed · 1998 · 42 citations

, , +13

Rows per page

1–5 of 10